Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shi-Ming Tu

Concepts (115)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Shi-Ming Tu's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Shi-Ming Tu has written about over time.
Neoplastic Stem Cells, 3 publications between 2002 and 2016, average publication date August 2009. Neoplasm Recurrence, Local, 6 publications between 2006 and 2020, average publication date September 2010. Testicular Neoplasms, 17 publications between 2002 and 2022, average publication date June 2011. Neoplasms, 3 publications between 2002 and 2022, average publication date September 2011. Middle Aged, 20 publications between 2002 and 2022, average publication date January 2012. Neoplasm Metastasis, 6 publications between 2002 and 2022, average publication date September 2012. Prostatic Neoplasms, 7 publications between 2002 and 2021, average publication date March 2013. Male, 28 publications between 2002 and 2022, average publication date March 2013. Neoplasms, Germ Cell and Embryonal, 12 publications between 2006 and 2022, average publication date June 2013. Retrospective Studies, 12 publications between 2002 and 2022, average publication date July 2013. Seminoma, 4 publications between 2010 and 2018, average publication date March 2014. CA-125 Antigen, 1 publications between 2014 and 2014, average publication date September 2014. Drug Resistance, Neoplasm, 3 publications between 2010 and 2018, average publication date February 2015. Adenocarcinoma, 5 publications between 2009 and 2020, average publication date April 2015. Endodermal Sinus Tumor, 2 publications between 2013 and 2018, average publication date December 2015. Immunotherapy, 1 publications between 2017 and 2017, average publication date July 2017. Tissue Extracts, 1 publications between 2017 and 2017, average publication date July 2017. Glypicans, 1 publications between 2018 and 2018, average publication date May 2018. Up-Regulation, 1 publications between 2018 and 2018, average publication date May 2018.

To see the data from this visualization as text, click here.
Tu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description